(1997). Hepatitis B. In G. Peter (Ed.), 1997 red book: Report of the Committee on Infectious Diseases (24th ed., pp. 247–260). Elk Grove Village, IL: Author. Google Scholar André, F.E. (1989). Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am ...
The European Vaccine Action Plan 2015–2020 defined HBV control through immunisation as one of its major strategic goals [10]. Furthermore, to reach the goal of eliminating viral hepatitis as a public health threat in Europe by 2030, the action plan for the health sector response to viral hep...
In: Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention. Published May 31, 2018. Accessed October 22, 2020. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt04-hepb.html 19. Chou R, Blazina I, Bougatsos C, et al. Screening...
Each epitope was weighted according to the degree of success obtained in each assay (T-cell assay, B-cell assay, or MHC assay) performed, with greater relevance being therefore given to those with better chances. We thus obtained a set of possible vaccine candidates with lengths ranging from ...
Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth Vaccine, 35 (33) (2017), pp. 4094-4098 View PDFView articleGoogle Scholar 21 L. Benova, M.L. Dennis, I.L. Lange, et al. Two decades of antenatal and delive...
Despite the availability of a preventive vaccine, chronic Hepatitis B virus (HBV) infection remains a significant global health issue, affecting more than 350 million people worldwide. If left unmonitored or untreated, approximately one-third of these chronically infected individuals will develop end-...
Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level Vaccine, 31 (2013), pp. 506-513, 10.1016/j.vaccine.2012.11.029 View PDFView articleView in ScopusGoogle Scholar Evdokimov et al., 2017 K. Evdokimov, K. Sayasinh,...
By J.B. Handley As most readers of AoA know, the Hep B vaccine was added to the CDC’s childhood immunization schedule in the early 1990s, requires four doses before a child is eighteen months old, and is the only vaccine...
Firstly, some information such as the 2nd and 3rd doses of HepB vaccine and PVST was obtained through telephone follow-up, which may have resulted in information bias. Secondly, PVST outcomes were unavailable for roughly 40%, which may have led to underestimated EMTCT rate of HBV. Lastly, ...
which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for adm...